For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240126:nRSZ9806Aa&default-theme=true
RNS Number : 9806A PureTech Health PLC 26 January 2024
26 January 2024
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 25 January 2024
Number of ordinary shares purchased: 46,146
Highest price paid per share: 198.60p
Lowest price paid per share: 194.40p
Volume weighted average price paid per share: 196.93p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 18,931,009 ordinary
shares in treasury and has 270,537,150 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 270,537,150 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
25/01/2024 08:08:50 1106 198 XLON 00387110051TRLO0.1.1
25/01/2024 08:08:50 1106 198 XLON 00387110052TRLO0.1.1
25/01/2024 08:12:11 2 198.2 CHIX 00387110586TRLO0.1.1
25/01/2024 08:24:23 1106 198.4 XLON 00387113480TRLO0.1.1
25/01/2024 08:24:24 553 198.2 XLON 00387113489TRLO0.1.1
25/01/2024 08:24:24 134 198.2 TRQX 00387113490TRLO0.1.1
25/01/2024 08:24:27 37 198.2 CHIX 00387113497TRLO0.1.1
25/01/2024 08:29:42 300 198.2 BATE 00387114223TRLO0.1.1
25/01/2024 08:29:42 219 198.2 AQXE 00387114224TRLO0.1.1
25/01/2024 08:29:42 30 198.2 AQXE 00387114225TRLO0.1.1
25/01/2024 08:29:42 253 198.2 BATE 00387114226TRLO0.1.1
25/01/2024 08:29:42 553 198 XLON 00387114228TRLO0.1.1
25/01/2024 08:29:42 514 198.2 CHIX 00387114227TRLO0.1.1
25/01/2024 08:29:42 553 198 XLON 00387114229TRLO0.1.1
25/01/2024 08:29:42 35 197.6 XLON 00387114231TRLO0.1.1
25/01/2024 08:29:42 215 198 XLON 00387114230TRLO0.1.1
25/01/2024 08:29:42 408 197.6 XLON 00387114232TRLO0.1.1
25/01/2024 09:19:23 39 197.8 XLON 00387122236TRLO0.1.1
25/01/2024 09:19:23 2726 197.8 XLON 00387122237TRLO0.1.1
25/01/2024 09:19:25 80 197.6 CHIX 00387122238TRLO0.1.1
25/01/2024 09:43:41 553 197.6 BATE 00387125785TRLO0.1.1
25/01/2024 09:43:41 3 197.6 AQXE 00387125787TRLO0.1.1
25/01/2024 09:43:41 127 197.6 BATE 00387125786TRLO0.1.1
25/01/2024 09:43:41 249 197.6 AQXE 00387125788TRLO0.1.1
25/01/2024 09:43:41 87 197.6 AQXE 00387125789TRLO0.1.1
25/01/2024 09:43:41 426 197.6 BATE 00387125790TRLO0.1.1
25/01/2024 09:43:41 412 197.6 CHIX 00387125791TRLO0.1.1
25/01/2024 09:43:41 97 197.6 CHIX 00387125793TRLO0.1.1
25/01/2024 09:43:41 517 197.6 CHIX 00387125792TRLO0.1.1
25/01/2024 09:43:41 2212 197.4 XLON 00387125794TRLO0.1.1
25/01/2024 09:43:41 46 197.6 TRQX 00387125796TRLO0.1.1
25/01/2024 09:43:41 72 197.6 TRQX 00387125795TRLO0.1.1
25/01/2024 09:43:41 62 197.6 TRQX 00387125797TRLO0.1.1
25/01/2024 09:44:18 222 196.8 XLON 00387125935TRLO0.1.1
25/01/2024 09:44:18 470 196.8 XLON 00387125934TRLO0.1.1
25/01/2024 09:56:04 759 196.8 XLON 00387127897TRLO0.1.1
25/01/2024 09:56:04 591 196.8 XLON 00387127898TRLO0.1.1
25/01/2024 09:56:04 862 196.8 XLON 00387127899TRLO0.1.1
25/01/2024 09:56:08 104 196 CHIX 00387127906TRLO0.1.1
25/01/2024 10:03:46 235 196.8 XLON 00387129091TRLO0.1.1
25/01/2024 10:03:46 339 196.8 XLON 00387129092TRLO0.1.1
25/01/2024 10:10:58 822 196.8 XLON 00387130156TRLO0.1.1
25/01/2024 10:15:31 34 196.8 XLON 00387131111TRLO0.1.1
25/01/2024 10:37:14 258 196.2 AQXE 00387135078TRLO0.1.1
25/01/2024 10:37:14 449 196.2 CHIX 00387135079TRLO0.1.1
25/01/2024 10:37:14 212 196.2 CHIX 00387135080TRLO0.1.1
25/01/2024 10:37:14 188 196.2 CHIX 00387135081TRLO0.1.1
25/01/2024 10:37:14 1000 196.2 XLON 00387135082TRLO0.1.1
25/01/2024 10:37:14 57 196.2 TRQX 00387135084TRLO0.1.1
25/01/2024 10:37:14 139 196.2 TRQX 00387135083TRLO0.1.1
25/01/2024 10:37:14 947 196.2 XLON 00387135085TRLO0.1.1
25/01/2024 10:59:50 553 195.4 BATE 00387138778TRLO0.1.1
25/01/2024 10:59:50 2212 195.4 XLON 00387138779TRLO0.1.1
25/01/2024 11:04:36 652 195.2 XLON 00387139816TRLO0.1.1
25/01/2024 11:04:36 151 195.2 XLON 00387139817TRLO0.1.1
25/01/2024 12:33:46 1931 195.6 XLON 00387154347TRLO0.1.1
25/01/2024 12:33:46 441 195.2 BATE 00387154349TRLO0.1.1
25/01/2024 12:33:46 281 195.6 XLON 00387154348TRLO0.1.1
25/01/2024 12:33:47 112 195.2 BATE 00387154358TRLO0.1.1
25/01/2024 12:33:47 553 195.2 CHIX 00387154360TRLO0.1.1
25/01/2024 12:33:47 26 195.2 TRQX 00387154361TRLO0.1.1
25/01/2024 12:33:47 134 195.2 TRQX 00387154362TRLO0.1.1
25/01/2024 12:33:47 246 194.8 AQXE 00387154370TRLO0.1.1
25/01/2024 12:33:47 54 194.8 AQXE 00387154371TRLO0.1.1
25/01/2024 12:33:47 13 194.8 AQXE 00387154372TRLO0.1.1
25/01/2024 12:33:58 86 194.8 AQXE 00387154389TRLO0.1.1
25/01/2024 12:48:44 1659 194.4 XLON 00387156882TRLO0.1.1
25/01/2024 13:21:22 246 194.8 CHIX 00387163227TRLO0.1.1
25/01/2024 13:21:22 1 195 CHIX 00387163228TRLO0.1.1
25/01/2024 13:21:22 126 195.2 CHIX 00387163229TRLO0.1.1
25/01/2024 13:21:22 72 195.2 CHIX 00387163230TRLO0.1.1
25/01/2024 14:41:04 249 196.2 AQXE 00387192432TRLO0.1.1
25/01/2024 14:41:04 249 196.2 AQXE 00387192433TRLO0.1.1
25/01/2024 14:41:04 120 196 CHIX 00387192434TRLO0.1.1
25/01/2024 14:41:04 433 196 CHIX 00387192435TRLO0.1.1
25/01/2024 14:41:04 509 196 XLON 00387192436TRLO0.1.1
25/01/2024 14:41:04 612 196 XLON 00387192437TRLO0.1.1
25/01/2024 14:41:04 538 196 XLON 00387192438TRLO0.1.1
25/01/2024 14:41:04 1145 196 XLON 00387192439TRLO0.1.1
25/01/2024 14:41:08 7 196.2 TRQX 00387192456TRLO0.1.1
25/01/2024 14:41:08 63 196.6 TRQX 00387192457TRLO0.1.1
25/01/2024 14:41:12 68 196 XLON 00387192491TRLO0.1.1
25/01/2024 14:41:12 16 196 XLON 00387192492TRLO0.1.1
25/01/2024 14:41:38 307 196 XLON 00387192697TRLO0.1.1
25/01/2024 14:41:45 263 196 XLON 00387192739TRLO0.1.1
25/01/2024 15:00:38 109 197.8 CHIX 00387204373TRLO0.1.1
25/01/2024 15:09:54 11 198 CHIX 00387210745TRLO0.1.1
25/01/2024 15:09:54 105 198 CHIX 00387210746TRLO0.1.1
25/01/2024 15:09:54 746 198 CHIX 00387210747TRLO0.1.1
25/01/2024 15:09:54 240 198 CHIX 00387210748TRLO0.1.1
25/01/2024 15:18:34 297 198 AQXE 00387216127TRLO0.1.1
25/01/2024 15:18:34 553 198 BATE 00387216128TRLO0.1.1
25/01/2024 15:18:34 300 198 CHIX 00387216129TRLO0.1.1
25/01/2024 15:18:34 149 198 CHIX 00387216130TRLO0.1.1
25/01/2024 15:18:34 73 198 CHIX 00387216131TRLO0.1.1
25/01/2024 15:18:34 31 198 CHIX 00387216132TRLO0.1.1
25/01/2024 15:18:34 524 198 XLON 00387216133TRLO0.1.1
25/01/2024 15:18:34 543 198 XLON 00387216135TRLO0.1.1
25/01/2024 15:18:34 39 198 XLON 00387216134TRLO0.1.1
25/01/2024 15:27:28 21 198.4 XLON 00387220570TRLO0.1.1
25/01/2024 15:30:01 372 198.4 XLON 00387221552TRLO0.1.1
25/01/2024 15:45:37 201 198 AQXE 00387229891TRLO0.1.1
25/01/2024 15:45:37 2601 198 XLON 00387229892TRLO0.1.1
25/01/2024 15:45:37 164 198 XLON 00387229893TRLO0.1.1
25/01/2024 15:45:38 240 198.2 TRQX 00387229894TRLO0.1.1
25/01/2024 15:45:38 92 198.4 TRQX 00387229895TRLO0.1.1
25/01/2024 15:45:41 30 198.2 BATE 00387229907TRLO0.1.1
25/01/2024 15:57:29 279 197.4 CHIX 00387236011TRLO0.1.1
25/01/2024 15:57:29 109 197.4 CHIX 00387236012TRLO0.1.1
25/01/2024 16:00:37 527 198 XLON 00387237598TRLO0.1.1
25/01/2024 16:00:44 2 198 XLON 00387237639TRLO0.1.1
25/01/2024 16:05:06 15 198 XLON 00387239264TRLO0.1.1
25/01/2024 16:05:06 170 198 XLON 00387239265TRLO0.1.1
25/01/2024 16:05:12 95 198 XLON 00387239292TRLO0.1.1
25/01/2024 16:05:12 493 198 XLON 00387239293TRLO0.1.1
25/01/2024 16:05:57 29 198.2 TRQX 00387239621TRLO0.1.1
25/01/2024 16:06:50 1 198 TRQX 00387239967TRLO0.1.1
25/01/2024 16:07:25 1 198 TRQX 00387240206TRLO0.1.1
25/01/2024 16:07:43 1 198 TRQX 00387240321TRLO0.1.1
25/01/2024 16:08:17 1 198 TRQX 00387240579TRLO0.1.1
25/01/2024 16:09:01 1 198 TRQX 00387240886TRLO0.1.1
25/01/2024 16:11:12 93 198 XLON 00387241740TRLO0.1.1
25/01/2024 16:17:02 7 198.6 CHIX 00387245446TRLO0.1.1
25/01/2024 16:17:51 233 198.6 CHIX 00387245991TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFVALDIEFIS